Wistar Appoints Ami Patel as Caspar Wistar Fellow

The Wistar Institute announces the appointment of Ami Patel, Ph.D., as a Caspar Wistar Fellow in the Vaccine and Immunotherapy Center.
14-Sep-2020 12:35 PM EDT Add to Favorites

Scientists Engineer DNA-based Nanotechnology to Stimulate Potent Antitumor Immune Responses in Preclinical Models

Combining their expertise in protein engineering and synthetic DNA technology, Wistar scientists successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.
10-Sep-2020 11:30 AM EDT Add to Favorites

The BEAT-HIV Martin Delaney Collaboratory Issues Recommendations on Measuring Persistent HIV Reservoirs in Cure-directed Clinical Trials

Wistar scientists and top HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the...
7-Sep-2020 9:10 AM EDT Add to Favorites

Breast Cancer Cells Use Message-carrying Vesicles to Send Oncogenic Stimuli to Neighboring Normal Cells

According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.
10-Aug-2020 12:20 PM EDT Add to Favorites

New Sugar-based Signature Identifies T Cells Where HIV Hides and Persists Despite Antiretroviral Therapy

Wistar scientists may have discovered a new way of identifying and targeting hidden HIV viral reservoirs during treatment with antiretroviral therapy (ART).
7-Aug-2020 10:30 AM EDT Add to Favorites

New Molecular Mechanism Involved in Cellular Senescence That Modulates Inflammation and Response to Cancer Immunotherapy

Wistar scientists discovered a novel pathway that enables detection of DNA in the cytoplasm and triggers inflammation and cellular senescence. This pathway may be modulated during senescence-inducing chemotherapy to affect cancer cell response to...
19-Feb-2020 10:55 AM EST Add to Favorites

Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China

Wistar announces today that they are part of a team to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has infected hundreds in China and other countries, including the U.S., and resulted in numerous deaths to...
23-Jan-2020 1:50 PM EST Add to Favorites

The Wistar Institute Received Nearly $2.5M in Philanthropic Support

In the past six months, scientists at The Wistar Institute received funding from private foundations totaling $2,418,000 that will fuel new discoveries in cancer, immunology and infectious diseases.
19-Dec-2019 4:20 PM EST Add to Favorites

See All News